• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About
  • Consumer Info
  • Guideline Notes
  • Medicine and Media
  • Pharmacogenomics
  • Visit My Etsy Store

Digital PharmD

Informatics in Pharmacy

GERD, PUD, Stress Ulcer Prophylaxis

August 12, 2018 By Dr. G, PharmD

Print Friendly, PDF & Email

GERD (gastroesophageal reflux disease)

Only screen for H. pylori in the case of PUD, history of documented peptic ulcer disease or gastric mucosa-associated lymphoma.  No endoscopy needed unless there are alarm symptoms.

Lifestyle Modifications:

  • Avoid alcohol, caffeine, chocolate, citrus, garlic, onions and mint
  • Reduce fat
  • Avoid eating 2-3 hours before bedtime
  • Remain upright for 2 hours after meals
  • Weight loss
  • Discontinue nicotine
  • Elevate the head of the bed
  • Avoid tight-fitting clothes
  • Avoid meds that lower LES (alpha antagonists, calcium channel blockers, anticholinergics, theophylline, BZDs, opiates) or delay gastric emptying (opiates, tricyclic antidepressants, calcium channel blockers, progesterone) or irritate stomach (NSAIDs, ASA, corticosteroids)

Treatment:

  • In patients without evidence of erosion, start with OTC antacids.  Move up to PPIs.
  • Erosive esophagitis must be treated for at least 8 weeks with PPIs.  Treat for 4 weeks if no erosion.
  • Can add promotility agents with diagnostic evaluation.

Peptic Ulcer Disease:

  • Usually H. pylori (see treatment).  NSAIDS (ibuprofen, diclofenac are less toxic than naproxen)
  • PPIs are the preferred gastroprotective agents for treatment and prevention of NSAID-associated GI injury.  Higher risk in 1st 3 months of NSAID use.
  • Naproxen is the only NSAID with no cardiovascular risk.  Less likely to have GI effects than some.
  • Misoprostol is effective for healing and secondary prevention of NSAID induced ulcers, but more GI side effects than PPI.  Misoprostol has a sulfa moiety.
  • Cox-2 inhibitors should be used as last line therapy.  Increase cardiovascular risk, decrease GI toxicity
  • Ibuprofen attenuates aspirin antiplatelet effects.  Space ibuprofen 30 minutes before or 8 hours after ASA.

GI Bleed:

  • The first step is volume resuscitation with a crystalloid or colloid if hemoglobin < 7.
  • Endoscopy withing 12-24 hours.
  • Remove meds contributing to bleeding, and start PPI therapy. Do not use H2R2 or octreotide.
  • Test for H Pylori.
  • IV PPI bolus and drip for 72 hours.  Oral PPI for 8 weeks.
  • DC both aspirin and clopidogrel.  Monitor for ischemic events.  Hold until bleed is resolved.

Stress Ulcer Prophylaxis:

  • Only for patients who are in the ICU when:
    • been on the vent for greater than 48 hours
    • <50,000 platelets
    • thermal injury
    • severe head or spinal cord injury
    • GI bleed in past year
    • low intragastric pH
    • major surgery lasting more than 4 hours
    • acute lung injury
  • Or at least two of the below:
    • sepsis
    • ICU stay exceeds one week
    • occult bleeding
    • high dose steroids
    • hepatic failure
    • acute renal insufficiency
    • hypotension
    • anticoagulation
  • Treatment: Antacids, sucralfate, H2RA or PPIs

Filed Under: Gastrointestinal

Primary Sidebar

Newsletter

More to See

What You Need to Know About the 2022 Avian Influenza Outbreak

March 20, 2022 By Dr. G, PharmD

Endocarditis Guideline Review

February 24, 2022 By Dr. G, PharmD

Sinus Troubles: When Should I See My Doctor

January 5, 2022 By Dr. G, PharmD

Tags

acid base acidosis acute coronary syndrome alkalosis analgesics anaphylaxis aortic dissection arrhythmia Beta-Blockers biostatistics blood pressure cardiac markers CHA2DS2-VasC cocaine COVID-19 diabetes diabetes inspidius Guidelines heart failure Heparin hypersensitivity hypertension hypovolemic shock intubation ionotropes journal club lipids LMWH medication safety morphine conversions myocardial infarction needs work NOAC NSTEMI obstructive shock pharmacoeconomics pheochromocytoma pressors reference materials right mi sedation septic shock shock STEMI Updated 2020

Footer

Medical Disclaimer

The medical information on this website is provided “as is” without any representations or warranties, express or implied. GoPharmD makes no representations or warranties in relation to the medical information on this website.

GoPharmD does not warrant that:

  • the medical information on this website will be constantly available, or available at all; or
  • the medical information on this website is complete, true, accurate, up-to-date, or non-misleading.
  • You must not rely on the information on this website as an alternative to medical advice from your doctor or other professional healthcare provider.
  • If you have any specific questions about any medical matter you should consult your doctor or other professional healthcare provider.

Recent

  • Smoking
  • What You Need to Know About the 2022 Avian Influenza Outbreak
  • Endocarditis Guideline Review
  • Sinus Troubles: When Should I See My Doctor
  • Common Pharmacogenomic SNPs and Interactions

Search

Tags

acid base acidosis acute coronary syndrome alkalosis analgesics anaphylaxis aortic dissection arrhythmia Beta-Blockers biostatistics blood pressure cardiac markers CHA2DS2-VasC cocaine COVID-19 diabetes diabetes inspidius Guidelines heart failure Heparin hypersensitivity hypertension hypovolemic shock intubation ionotropes journal club lipids LMWH medication safety morphine conversions myocardial infarction needs work NOAC NSTEMI obstructive shock pharmacoeconomics pheochromocytoma pressors reference materials right mi sedation septic shock shock STEMI Updated 2020